Czech Pharmaco-epidemiological Study on Disease Modifying Drugs

Condition:   Multiple Sclerosis Intervention:   Drug: interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab Sponsor:   IMPULS Endowment Fund Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials